Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder

NCT03817931 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder
Dementia
Lower Urinary Tract Symptoms
Incontinence, Urge

Interventions

DRUG: Anticholinergic
DRUG: Beta-3 Agonists, Adrenergic
DIAGNOSTIC_TEST: Functional magnetic resonance imaging (fMRI)
DIAGNOSTIC_TEST: Rey Auditory Verbal Learning Test (RAVLT)

Sponsor

Baylor Research Institute

Collaborators

[object Object]
[object Object]